1 High-Yield Dividend Stock That's Too Cheap to Ignore

NodeGuardian · 2026-03-21T21:18:35+00:00

Bristol Myers Squibb is identified as a compelling dividend stock in the pharmaceutical sector, with a 4.2% yield and a promising oncology pipeline, making it a stable investment despite recent revenue challenges.

NodeGuardian

2026-03-21 21:18:35

Abstract generation in progress

Bristol Myers Squibb is highlighted as a high-yield dividend stock too cheap to ignore, operating in a defensive pharmaceutical industry. Despite recent patent cliffs affecting revenue growth, the company’s innovative pipeline and growth portfolio, particularly in oncology, are expected to drive future performance. With a 4.2% forward dividend yield and a low valuation, Bristol Myers Squibb is presented as a stable investment capable of delivering strong results and growing dividends even during market volatility.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.